Bothell-based BioLife Solutions posts earning results for 2016

BioLife Solutions is a Bothell-based company. Contributed art

The following is from a release by BioLife Solutions:

Bothell-based BioLife Solutions, Inc. has reported operational highlights and financial results for the fourth quarter and full year of 2016.

The company is a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media.

Revenue from biopreservation media product sales reached a new high of $2.3 million in the fourth quarter of 2016, an increase of 24 percent over the same period in 2015. For the full year of 2016, revenue totaled a record $8.2 million, a 28 percent increase compared to $6.4 million in 2015. Revenue growth for both periods was driven by increased sales of CryoStor and HypoThermosol clinical grade biopreservation media products to the regenerative medicine segment, including increased order volume from later stage clinical customers that are developing CAR T-cell and other cellular immunotherapies for cancer and other leading causes of death.

“We are completely focused on executing our strategy to achieve our goal of positive quarterly EBITDAS by the end of the year,” said BioLife President and CEO Mike Rice. “We expect that a combination of continued revenue growth from the regenerative medicine market segment and lower operating expenses will enable BioLife to reach this milestone. 2017 could be a pivotal year for BioLife, with anticipated customer approvals of their cell therapies, and further adoption of CryoStor and HypoThermosol by new entrants in the high growth regenerative medicine market.”

2016 Operational Highlights

· 123 new customers were gained in 2016, including 65 in the high growth regenerative medicine market segment.

· Long term supply agreements were signed with Kite Pharma, Bellicum Pharmaceuticals, and TissueGene, illustrating our critical supplier role with these late stage clinical customers.

· Management estimates CryoStor and HypoThermosol are now incorporated in 250 regenerative medicine applications.

· Completed the restructuring of the biologistex JV with SAVSU, significantly reducing future cash outflows while maintaining a strong financial interest in the success of this disruptive cold chain management technology platform.

Q4 and 2016 Financial Results

· Gross margin was 61 percent for the fourth quarter and 58 percent for the full year of 2016.

· Total consolidated operating expenses for the fourth quarter were $2.0 million compared to $2.4 million in the third quarter of 2016. For the full year of 2016, consolidated operating expenses totaled $9.6 million compared to $8.8 million in 2015.

· Consolidated operating loss for the fourth quarter was $0.6 million compared to $1.1 million in the third quarter of 2016, and $1.4 million in the fourth quarter of 2015. Consolidated operating loss for the full year of 2016 was $4.9 million compared to $5.0 million in 2015.

· Net loss attributable to BioLife was $3.3 million for the fourth quarter of 2016, and included a one-time, non-cash loss on deconsolidation charge of $2.8 million related to the company’s restructuring of its biologistex joint venture. Excluding this charge, the net loss attributable to BioLife for the fourth quarter was $0.5 million compared to $1.1 million in the fourth quarter of 2015. Net loss attributable to BioLife for 2016 was $6.9 compared to $4.2 million in 2015. Excluding the one-time, non-cash loss on deconsolidation, net loss for 2016 was $4.1 million vs. $4.2 million in 2015.

2017 Catalysts:

· A number of cell therapy customers, including Kite Pharma, Kiadis Pharma and Kolon Life Sciences, are seeking regulatory approvals to commence marketing and commercial manufacturing in 2017, which, as a result, should drive increased demand for our proprietary biopreservation media products.

· Continued adoption of CryoStor and HypoThermosol in pre-IND validations and phase 1, 2 and 3 clinical trials of new cell and tissue based products and therapies.

· Adoption of the evo Smart Shipper and use of the biologistex Cold Chain Management SaaS by leading cell therapy companies.

2017 Guidance

Management reaffirms the full-year 2017 guidance provided in January as follows:

· Biopreservation media revenue is expected to grow between 20-25 percent over 2016, with revenue in excess of $10 million.

· Gross Margin is expected in a range of 55-60 percent.

· Annual operating expenses are expected to range from $8 to $9 million.

· Positive quarterly EBITDAS by the end of 2017.


In consideration of how we voice our opinions in the modern world, we’ve closed comments on our websites. We value the opinions of our readers and we encourage you to keep the conversation going.

Please feel free to share your story tips by emailing editor@bothell-reporter.com.

To share your opinion for publication, submit a letter through our website https://www.bothell-reporter.com/submit-letter/. Include your name, address and daytime phone number. (We’ll only publish your name and hometown.) We reserve the right to edit letters, but if you keep yours to 300 words or less, we won’t ask you to shorten it.

More in Business

The Guest House co-owner Kevin Kearney in the kitchen. Photo courtesy of Shehab Hossain/Imaginoor Photography
The Guest House in Kenmore announces temporary closure

Before then, the restaurant had been diligently updating its protocols amid COVID-19 concerns.

Sound Publishing operates the following titles in King County: Federal Way Mirror, Auburn Reporter, Kent-Covington Reporter, Renton Reporter, Enumclaw Courier-Herald, Kirkland Reporter, Bellevue Reporter, Snoqualmie Valley Record, Issaquah Reporter, Redmond Reporter, Bothell-Kenmore Reporter, Mercer Island Reporter and the Vashon-Maury Island Beachcomber.
Bothell-Kenmore Reporter to suspend print publication

As the coronavirus pandemic continues to rapidly evolve across the globe, the… Continue reading

COVID-19 gathering restriction delays funerals

For one funeral home owner, the confusion came to a head after a recent service.

Carolina Smoke owner David Hayward packages up orders to go on March 22 in Bothell. Olivia Vanni/staff photo
Carolina Smoke in Bothell offers down-home barbecue comfort

During the shutdown, take home an order of restaurant owner David Hayward’s brisket, pulled pork, ribs and sides.

Bothell spirits maker now producing hand sanitizer

Wildwood Spirits Co. has decided to give the community something it’s lacking.

For sale sign hanging in front of house. File photo
Open houses close due to coronavirus concerns

Northwest Multiple Listing Service halts large group home tours amid pandemic.

Real estate: coronavirus, mortgage rates and inventory

As the virus has spread across the world the Federal Reserve has issued a surprise interest rate cut.

Bellevue skyline. File photo
Amid coronavirus concerns, Eastside cities are taking preventative steps

Most Eastside cities are following recommendations from county officials.

A flight takes off at SeaTac International Airport. Photo courtesy Port of Seattle
Port of Seattle, airlines respond to COVID-19 with new health measures

Changes at Sea-Tac Airport include more hand sanitizer, training for biohazard cleaning.

With Mount Baker and Jetty Island in the distance, a container ship approaches the Port of Everett. (Port of Everett photo)
Senate Dems: $5 million to help businesses disrupted by coronavirus

Overseas port closures hurt WA companies that depend on international shipping.

Bothell and Kenmore housing market shows early signs of spring

A snapshot of the local real estate market.

Bothell-Kenmore chamber holds first general meeting of the year

It took place at the Northshore Senior Center on Jan. 23.